Oxygen clues could unlock better cervical cancer treatment
NCT ID NCT05029258
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find biological markers (biomarkers) that show which cervical cancers have low oxygen levels, making them harder to treat with standard radiation. About 30 patients with advanced cervical cancer will have special MRI scans and tumor biopsies before and during treatment. The goal is to better identify who might benefit from therapies that target low-oxygen tumors, improving survival and reducing side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Christie NHS Foundation Trust
Manchester, Greater Manchester, M20 4BX, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Could a genetic marker guide future cancer therapies in taiwan?
- AI takes on cancer radiotherapy: can a computer plan treatment in minutes?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells
- Can acupuncture help women regain bladder control after hysterectomy?